News

  • Krka Receives Award for Best Annual Report Again

    At this year’s contest for best annual report of 2019, organised by the Slovenian business daily Finance, Krka was announced the winner in the large company category.

  • Krka receives two awards from the Slovenian Chamber of Commerce and Industry for innovation

    Krka was once again awarded in the category of best innovation by the Slovenian Chamber of Commerce and Industry. Krka received two awards: the gold award for a substitute medicine with a triple combination used in the treatment of high blood pressure, and the silver award for innovation, which helped us increase our production capacity and improve the quality of valsartan’s active ingredient.

  • Krka Reports Business Results for the First Nine Months Ended 30 September 2020

    In the first three quarters of 2020, the Krka Group generated sales of €1,160.2 million, a 6% increase compared to the first three quarters last year, yielding €210.1 million of net profit, up 22% year on year. At its regular meeting yesterday, the Supervisory Board of Krka discussed the Krka Group and Krka interim reports for the first nine months ended 30 September 2020.

  • Dear pharmacists, thank you for your support

    This year has brought many changes, and pharmacists have played an especially important role in providing for people’s health.

  • Let’s talk about dementia

    The average life expectancy and, consequently, the incidence of Alzheimer's disease have been increasing over the past few decades; Alzheimer’s disease affects 5-10% of the population over 65.